Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment
Authors:
Open Access
- 1 May 2011
- journal article
- review article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (5) , 1237-1245
Abstract
Context: Medullary thyroid carcinoma (MTC) is diagnosed only after thyroidectomy in approximately 10–15% of cases. This delay in diagnosis can have adverse consequences such as missing underlying pheochromocytoma or hyperparathyroidism in unrecognized multiple endocrine neoplasia type 2 and choosing a suboptimal extent of surgery. Barriers to accurate preoperative diagnosis and management strategies after the discovery of occult MTC are reviewed. Evidence Acquisition: We reviewed PubMed (1975-September 2010) using the search terms medullary carcinoma, calcitonin, multinodular goiter, Graves' disease, calcium/diagnostic use, and pentagastrin/diagnostic use. Evidence Synthesis: The combined prevalence of occult MTC in thyroidectomy series is approximately 0.3%. Routine calcitonin measurement in goiter patients identifies C-cell hyperplasia as well as MTC. Challenges include interpreting intermediate values and unavailability of pentagastrin stimulation testing in the United States. Early studies have begun to identify appropriate cutoff values for calcium-stimulated calcitonin. For management of incidentally discovered MTC, we highlight the role of early measurement of calcitonin and carcinoembryonic antigen, RET testing, and comprehensive neck ultrasound exam to direct further imaging, completion thyroidectomy, and lymph node dissection. Conclusions: Occult MTC is an uncommon, but clinically significant entity. If calcium stimulation testing cutoff data become well-validated, calcitonin screening would likely become more widely accepted in the diagnostic work-up for thyroid nodules in the United States. Among patients with incidental MTC, those with persistently elevated serum calcitonin levels, positive RET test, or nodal disease are good candidates for completion thyroidectomy and lymph node dissection in selected cases, whereas patients with undetectable calcitonin, negative RET testing, and no sonographic abnormalities often may be watched conservatively.Keywords
This publication has 54 references indexed in Scilit:
- Shear Wave Elastography: A New Ultrasound Imaging Mode for the Differential Diagnosis of Benign and Malignant Thyroid NodulesThe Journal of Clinical Endocrinology & Metabolism, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid CarcinomaClinics, 2009
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid AssociationThyroid®, 2009
- Ultrasonographic Findings of Medullary Thyroid Carcinoma: a Comparison with Papillary Thyroid CarcinomaKorean Journal of Radiology, 2009
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Adverse Drug Reactions in Patients with PhaeochromocytomaDrug Safety, 2007
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Surgical Treatment of Thyroid Cancers With Concurrent Graves DiseaseAnnals of Surgical Oncology, 2004
- Cytologic diagnosis of medullary carcinoma of the thyroid glandDiagnostic Cytopathology, 2000